- Home
- BSET vs CNTB Comparison
BSET vs CNTB Comparison
Compare BSET & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | CNTB |
|---|---|---|
| Founded | 1902 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.9M | 140.4M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BSET | CNTB |
|---|---|---|
| Price | $21.22 | $0.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $5.88 |
| AVG Volume (30 Days) | 21.1K | ★ 2.0M |
| Earning Date | 09-30-2026 | 11-11-2026 |
| Dividend Yield | ★ 3.82% | N/A |
| EPS Growth | ★ 163.06 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $456,855,000.00 | $64,000.00 |
| Revenue This Year | $0.85 | $11,292.49 |
| Revenue Next Year | $3.42 | $114.35 |
| P/E Ratio | $34.33 | ★ N/A |
| Revenue Growth | ★ 0.96 | N/A |
| 52 Week Low | $13.17 | $0.89 |
| 52 Week High | $22.26 | $3.82 |
Technical Indicators
Market Signals| Indicator | BSET | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 71.87 | 38.32 |
| Support Level | $13.90 | N/A |
| Resistance Level | $22.26 | $2.78 |
| Average True Range (ATR) | 0.68 | 0.12 |
| MACD | 0.40 | -0.01 |
| Stochastic Oscillator | 96.51 | 6.10 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.